We’re excited to announce that GSK, one of the world’s leading research-based pharmaceutical and healthcare companies, is returning! GSK experts are here to include dads in very important conversations about the vaccines our older children need to help protect against meningitis:
- Although uncommon, about one in 10 people infected with meningitis will die, while approximately one in five survivors will suffer long-term consequences, which may include deafness, nervous system problems, brain damage or loss of limbs.i
- Early symptoms are similar to those of a cold or the flu but can progress quickly and be fatal, sometimes within 24 hours.ii
- Adolescents and young adults are at an increased risk for meningitis due to behaviors like living in close quarters, sharing drinks or eating utensils, kissing or coughing.iii, iv, v, vi
- Serogroup B has been responsible for 100 percent of US college outbreaks of meningococcal disease from 2011 through March 2019, which involved 13 campuses, 50 cases, and 2 deaths among an at-risk population of approximately 253,000 students.
- Recent CDC data show that from 2017 through 2018 only about 17 percent of 17-year-olds have received at least one dose of MenB vaccine.vii
We will be joined by Pediatrician and Vice President, Director Scientific Affairs & Public Health, GSK Vaccines, Dr. Leonard Friedland, a doctor and a dad who can help you make sense of the vaccines for your family. Join us to get the information you need to educate both your family and your audience about meningitis vaccination, and meet a dad and sister with firsthand knowledge of the importance of meningitis vaccination.
GSK takes a very educational approach to working with influencers, and this year is another chance to meet the GSK team and talk about how you and your community can stay informed about vaccines.
i CDC. Meningococcal Disease: Clinical Information. Available here.
ii CDC. Meningococcal Disease: Signs and Symptoms: Available here.
iii Marshall GS, Dempsey AF, Srivastava, Isturiz RE. US college students are at increased risk for serogroup B meningococcal disease. JPIDS.2019:1-4.
iv CDC. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 8: Meningococcal Disease. Available here.
v CDC. Meningococcal Disease: Causes and Spread to Others. Available here.
vi Larimer County. Meningococcal Disease. Available here.
vii CDC. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years—United States, 2018.MMWR. 2019; 68(33):718-723.